JP2022544272A5 - - Google Patents
Info
- Publication number
- JP2022544272A5 JP2022544272A5 JP2022508779A JP2022508779A JP2022544272A5 JP 2022544272 A5 JP2022544272 A5 JP 2022544272A5 JP 2022508779 A JP2022508779 A JP 2022508779A JP 2022508779 A JP2022508779 A JP 2022508779A JP 2022544272 A5 JP2022544272 A5 JP 2022544272A5
- Authority
- JP
- Japan
- Prior art keywords
- diffraction pattern
- ray powder
- powder diffraction
- pattern containing
- fumarate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025113638A JP2025148406A (ja) | 2019-08-13 | 2025-07-04 | アクチビン受容体様キナーゼ阻害剤の塩及び結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962885977P | 2019-08-13 | 2019-08-13 | |
| US62/885,977 | 2019-08-13 | ||
| PCT/US2020/045847 WO2021030386A1 (en) | 2019-08-13 | 2020-08-12 | Salt and crystal forms of an activin receptor-like kinase inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025113638A Division JP2025148406A (ja) | 2019-08-13 | 2025-07-04 | アクチビン受容体様キナーゼ阻害剤の塩及び結晶形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544272A JP2022544272A (ja) | 2022-10-17 |
| JP2022544272A5 true JP2022544272A5 (cg-RX-API-DMAC10.html) | 2023-08-21 |
| JP7775186B2 JP7775186B2 (ja) | 2025-11-25 |
Family
ID=72193669
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022508779A Active JP7775186B2 (ja) | 2019-08-13 | 2020-08-12 | アクチビン受容体様キナーゼ阻害剤の塩及び結晶形態 |
| JP2025113638A Pending JP2025148406A (ja) | 2019-08-13 | 2025-07-04 | アクチビン受容体様キナーゼ阻害剤の塩及び結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025113638A Pending JP2025148406A (ja) | 2019-08-13 | 2025-07-04 | アクチビン受容体様キナーゼ阻害剤の塩及び結晶形態 |
Country Status (15)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3442977T3 (fi) * | 2016-04-15 | 2023-09-26 | Blueprint Medicines Corp | Aktiviinireseptorin kaltaisen kinaasin estäjät |
| CA3117695A1 (en) | 2018-10-26 | 2020-04-30 | Keros Therapeutics, Inc. | Crystal forms of an alk2 inhibitor |
| US12508262B2 (en) | 2020-04-30 | 2025-12-30 | Keros Therapeutics, Inc. | Methods of using ALK2 inhibitors |
| WO2022098812A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating iron overload |
| WO2026161341A1 (en) * | 2025-01-21 | 2026-07-30 | Blueprint Medicines Corporation | Drug product formulations of fidrisertib |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3442977T3 (fi) * | 2016-04-15 | 2023-09-26 | Blueprint Medicines Corp | Aktiviinireseptorin kaltaisen kinaasin estäjät |
| AR112027A1 (es) * | 2017-06-15 | 2019-09-11 | Biocryst Pharm Inc | Inhibidores de alk 2 quinasa que contienen imidazol |
-
2020
- 2020-08-12 MX MX2022001741A patent/MX2022001741A/es unknown
- 2020-08-12 CN CN202080057092.0A patent/CN114222745B/zh active Active
- 2020-08-12 EP EP20761085.8A patent/EP4013757A1/en active Pending
- 2020-08-12 TW TW109127433A patent/TWI870440B/zh active
- 2020-08-12 US US17/633,440 patent/US20220281879A1/en active Pending
- 2020-08-12 JP JP2022508779A patent/JP7775186B2/ja active Active
- 2020-08-12 BR BR112022002597A patent/BR112022002597A2/pt unknown
- 2020-08-12 AU AU2020328534A patent/AU2020328534B2/en active Active
- 2020-08-12 UA UAA202200733A patent/UA130650C2/uk unknown
- 2020-08-12 WO PCT/US2020/045847 patent/WO2021030386A1/en not_active Ceased
- 2020-08-12 JO JOP/2022/0014A patent/JOP20220014A1/ar unknown
- 2020-08-12 CN CN202411831775.3A patent/CN119638704A/zh active Pending
- 2020-08-12 CA CA3146701A patent/CA3146701A1/en active Pending
- 2020-08-12 KR KR1020227008160A patent/KR102967623B1/ko active Active
-
2022
- 2022-02-09 MX MX2024014312A patent/MX2024014312A/es unknown
- 2022-02-09 IL IL290482A patent/IL290482A/en unknown
- 2022-02-14 CO CONC2022/0001450A patent/CO2022001450A2/es unknown
-
2025
- 2025-07-04 JP JP2025113638A patent/JP2025148406A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6966590B2 (ja) | オメカムチブメカルビルの塩及び塩を調製するプロセス | |
| DK2498610T3 (en) | Selective sphingosine-1-phosphate receptor modulators and methods of chiral synthesis | |
| AU2012201453C1 (en) | Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | |
| EP2041093B1 (en) | Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases | |
| JP6832946B2 (ja) | キナーゼ阻害剤およびその中間体の調製方法 | |
| JP2005503386A5 (cg-RX-API-DMAC10.html) | ||
| BG107510A (bg) | Карбоксамидни съединения и тяхното използване като антагонисти на човешки 11 cby рецептор | |
| JP2013541592A5 (cg-RX-API-DMAC10.html) | ||
| JP2022551525A5 (cg-RX-API-DMAC10.html) | ||
| EP2619190B1 (en) | Substituted oxadiazole compounds and their use as s1p1 agonists | |
| EP3089976A1 (en) | Crystalline forms of afatinib di-maleate | |
| EP2707364B1 (en) | Process for the manufacture of dabigatran etexilate and intermediates thereof | |
| JP2024521412A5 (cg-RX-API-DMAC10.html) | ||
| JP2022523368A5 (cg-RX-API-DMAC10.html) | ||
| CN101448819A (zh) | (5s)-5-[4-(5-氯-吡啶-2-基氧基)-哌啶-1-磺酰基甲基]-5-甲基-咪唑烷-2,4-二酮的新晶体变化形式及其中间体 | |
| JP2024505063A5 (cg-RX-API-DMAC10.html) | ||
| JP2025131810A (ja) | タンパク質キナーゼ阻害剤としてのヘテロ環化合物の結晶形 | |
| JP2024523506A5 (cg-RX-API-DMAC10.html) | ||
| TWI374136B (en) | Water adduct of acetamide moohydrochloride and its crystal | |
| JP2018522945A5 (cg-RX-API-DMAC10.html) | ||
| CN1104435C (zh) | N-[(1-正丁基-4-哌啶基)甲基]-3,4-二氢-2H-[1,3] 噁嗪并[3,2-α]吲哚-10-甲酰胺及其盐的制备方法及在本方法中的中间体的制备方法 | |
| JP2024529533A5 (cg-RX-API-DMAC10.html) | ||
| CN102333762A (zh) | 乙胺类化合物及其在治疗抑郁症中的用途 | |
| RU2022103256A (ru) | Соль и кристаллические формы ингибитора активин-рецептороподобной киназы | |
| CN102300851A (zh) | 制备含羧基的吡唑酰氨基化合物597的新方法 |